FDA Investigator Marianela Aponte Cruz
Marianela Aponte Cruz has inspections in 12 countries as of 23 Oct 2023. Marianela Aponte Cruz has collaborated with a combined 3881 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
52
Last Inspection Date:
23 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
New Zealand,
United Kingdom of Great Britain and Northern Ireland,
France,
Poland,
Canada,
Australia,
Germany,
Italy,
Austria,
Mexico,
Argentina
Co-Investigator(s):
Adalberto Cajigas,
Adaliz Santaliz Cruz,
Alan A Rivera,
Alicia M Mozzachio,
Alonso,
An T Vu,
Ana P Pineda Zavaleta,
Anastasia M Shields,
Angelica M Hernandez,
Anissa M Vargas,
Anita R Michael,
Annette Melendez,
Anthony A Charity,
Anthony C Warchut,
April L Young,
Ariel Cruz Figueroa,
Arlene M Badillo,
Arsen Karapetyan,
Azza Talaat,
Barbara M Frazier,
Brenda Rivera,
Brenda S Zimmer, PhD,
Carla A Norris,
Carlos A Medina,
Carrie A Hughes,
CDR Ileana Barreto Pettit,
Charisse K Green,
Charles R Cote, RIC,
Christopher T Middendorf,
Colleen F Hoyt,
Dandan Wang, PhD,
Daniel J Roberts,
Daryl A Dewoskin,
David J Gomes,
David J Hafner,
Dayna I Martinez,
Debra I Love,
Debra J Bennett,
Dell S Moller,
Dennis Cantellops Paite,
Devaughn Edwards,
Doan T Nguyen, PharmD,
Donald L Lech,
Donna F Campbell,
Dorota Matecka, PhD,
Douglas A Campbell,
Dr. Carmelo Rosa,
Eddie A Santini,
Edwin Martinez,
Emest F Bizjak,
Erika V Butler,
Eva I Merced Medina,
Eva Merced,
Farhana Khan,
Felix Maldonado,
Frances L Dejesus,
Francis A Guidry,
Frederick L Fricke,
Fredrick L Fricke,
Geraldine D Sanders,
German Rivera,
Gwyn G Dickinson,
Hector J Colon Torres,
Heriberto Negron Rivera,
Ileana Pettit,
Iraida Ortiz,
Ivis L Negron,
Ivis Lnegron Torres,
Ivonne A Vicente,
Jaime E Pares,
James C Maclaughlin,
Javier O Vega,
Joan M Cantellops Figueroa,
Joanne E King,
Joe X Phillips,
Joel D Hustedt,
Jorge L Guadalupe,
Jorge L Lajara,
Jose A Moreno,
Jose Acruz Gonzalez,
Jose Alopez Rubet,
José E Meléndez,
Jose E Melendez, DDC,
Jose Fpedrode Jesus,
Jose M Cayuela,
Jose Perez Soto,
Jose R Hernandez,
Jose R Lopez,
Jose Velez,
Juan Rjimenez Garcia,
Junho Opak,
Junho Pak,
Justin A Boyd,
Karen A Wolnik,
Katherine Szestypalow,
Kathryn E Ogger,
Kevin P Foley,
Kim Lthomas Cruse,
Krishna Ghosh, PhD,
Lareese K Thomas,
Laura E Garcia,
Laurimer Kuilan Torres,
Lawrence J Stringer,
LCDR Michael H Tollon,
Leonard H Lavi,
Liatte Kreuger, PharmD,
Libia M Lugo,
Lisa M Lopez,
Lizaida E Rodriguez,
Lourdes Andujar,
LT Luis O Rodriguez,
LT Rafael Gonzalez,
Lucas B Leake,
Luis A Carrion,
Luz N Riveradecruz,
Margaret M Annes,
Margarita Santiago,
Maria Pkelly Doggett, MBA,
Marian E Ramirez,
Marianela Aponte,
Maribel V Juarbe,
Marie A Fadden,
Marie F Morin,
Marie T Falcone,
Marilyn Santiago,
Marisal Faberhe,
Marisol Faberlle,
Mark R Mcclain,
Marta E Gonzalez,
Marybet Lopez,
Matthew B Casale,
Matthew M Schuckmann,
Matthew R Dionne,
Medina,
Meisha R Sampson,
Meisha Waters,
Melissa J Garcia,
Mendoza,
Michael A Charles,
Michael A Taylor,
Michael C Rogers,
Michael E Maselli,
Michael L Casner,
Michael R Klapal,
Michele L Obert,
Miguel A Martinez,
Miguel Hernandez Sanchez,
Milva E Melendez,
Mra Davism,
Mra Mcculloughj,
Myriam M Sosa,
Nancy G Schmidt,
Nancy Rosado,
Neisa M Alonso,
Nicholas A Violand,
Nicholas L Hunt,
Nicole E Knowlton,
Niketa Patel,
Noreen Muniz,
Pablo Feliciano,
Parul M Patel,
Paul A Bonneau,
Philip F Istafanos, DMV, MS,
Rafael Nevarez,
Rafael Nevarez Nieves,
Rafeeq A Habeeb,
Rajiv R Srivastava,
Rakhi B Shah,
Ramon A Hernandez,
Rapti D Madurawe,
Raquel Gonzalez,
Raquel Gonzalez Rivera,
Reba A Gates,
Rebecca Parrilla,
Rebecca Rodriguez,
Regina T Brown,
Richard J Friedman,
Richmond K Yip,
Robert Sharpnack,
Rosa J Motta,
Rose J Motta,
Ruth Moore, PhD,
Saied A Asbagh,
Saleem A Akhtar,
Samuel T Walker,
Sandra A Boyd,
Sandra A Hughes,
Sangeeta M Khurana, PhD,
Santiago Gallardo Johnson,
Shirley J Berryman,
Simone E Pitts,
Sixto M Mercado,
Sixto M Mercado Rios,
Sonia M Monges,
Stacie A Woods,
State Agency,
Steven B Barber,
Steven B Hertz,
Steven D Kehoe,
Sue Lee Chan,
Susan M Jackson,
Susan P Bruederle,
Taichun Qin, PhD,
Tajah L Blackburn,
Tamil Arasu, PhD,
Ted L Anderson,
Theresa Kirkham (NMI),
Thomas J Arista,
Truong Xuan Nguyen (Andy),
Vilmary Negron Rodriguez,
Virgilio F Pacio, CSO,
Vlada Matusovsky,
Walden H Lee,
Wanda J Torres,
Ying Zhang,
Yumi J Hiramine,
Zuleika A Pineiro Vargas
Marianela Aponte Cruz's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more